Baird Financial Group, Inc. Merck & Co., Inc. Transaction History
Baird Financial Group, Inc.
- $50.4 Billion
- Q4 2024
A detailed history of Baird Financial Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 1,938,701 shares of MRK stock, worth $161 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
1,938,701
Previous 2,104,449
7.88%
Holding current value
$161 Million
Previous $239 Million
19.3%
% of portfolio
0.38%
Previous 0.48%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,899Shares Held
1.86BCall Options Held
16.1MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA251MShares$20.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.07 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.66 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $210B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...